Submitted by Anonymous (not verified) on 9 June 2026 - 15:25
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 14, Status: Authorised